MorphoSys (MOR) Short Interest Ratio & Short Volume → How this is some devastating news (From WealthPress) (Ad) Free MOR Stock Alerts $19.00 -0.34 (-1.76%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media MorphoSys Short Interest DataCurrent Short Volume1,250,000 sharesPrevious Short Volume1,530,000 sharesChange Vs. Previous Month-18.30%Dollar Volume Sold Short$21.76 millionShort Interest Ratio / Days to Cover0.9Last Record DateApril 30, 2024Outstanding Shares150,620,000 sharesPercentage of Shares Shorted0.83%Today's Trading Volume449,671 sharesAverage Trading Volume631,162 sharesToday's Volume Vs. Average71% Short Selling MorphoSys ? Sign up to receive the latest short interest report for MorphoSys and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMOR Short Interest Over TimeMOR Days to Cover Over TimeMOR Percentage of Float Shorted Over Time Ad DTIDon’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. MorphoSys Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,250,000 shares $21.76 million -18.3%N/A0.9 $17.41 4/15/20241,530,000 shares $27.57 million -6.1%N/A0.8 $18.02 3/31/20241,630,000 shares $29.57 million -22.0%N/A0.8 $18.14 3/15/20242,090,000 shares $37.29 million +1.5%N/A1 $17.84 2/29/20242,060,000 shares $36.26 million -1.0%N/A0.9 $17.60 2/15/20242,080,000 shares $36.38 million +52.9%N/A0.8 $17.49 Get the Latest News and Ratings for MOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,360,000 shares $14.29 million +38.1%N/A0.5 $10.51 1/15/2024985,000 shares $8.47 million -31.6%N/A0.8 $8.60 12/31/20231,440,000 shares $14.26 million +9.9%N/A1.4 $9.90 12/15/20231,310,000 shares $12.73 million +1.6%N/A1.4 $9.72 11/30/20231,290,000 shares $8.82 million +255.2%N/A1.7 $6.84 11/15/2023363,200 shares $2.52 million +485.8%N/A0.8 $6.95 10/31/202362,000 shares $494,140.00 +12.3%N/A0.3 $7.97 10/15/202355,200 shares $358,800.00 -18.3%N/A0.3 $6.50 9/30/202367,600 shares $454,272.00 -44.9%N/A0.4 $6.72 9/15/2023122,700 shares $986,508.00 -4.3%N/A0.7 $8.04 8/31/2023128,200 shares $961,500.00 +10.2%N/A0.7 $7.50 8/15/2023116,300 shares $890,858.00 +96.8%N/A0.6 $7.66 7/31/202359,100 shares $434,385.00 +135.5%N/A0.3 $7.35 7/15/202325,100 shares $196,784.00 -45.6%N/A0.1 $7.84 6/30/202346,100 shares $344,367.00 +21.0%N/A0.3 $7.47 6/15/202338,100 shares $269,367.00 +359.0%N/A0.3 $7.07 5/31/20238,300 shares $53,203.00 -69.9%N/A0.1 $6.41 5/15/202327,600 shares $166,428.00 -7.1%N/A0.2 $6.03 4/30/202329,700 shares $155,628.00 +3.5%N/A0.2 $5.24 4/15/202328,700 shares $149,240.00 -13.3%N/A0.3 $5.20 3/31/202333,100 shares $131,076.00 +51.1%N/A0.2 $3.96 3/15/202321,900 shares $81,906.00 +14.1%N/A0.2 $3.74 2/28/202319,200 shares $86,400.00 -63.9%N/A0.1 $4.50 2/15/202353,200 shares $265,468.00 +2.3%N/A0.3 $4.99 1/31/202352,000 shares $257,400.00 -65.0%N/A0.3 $4.95 1/15/2023148,700 shares $679,559.00 +75.2%N/A0.8 $4.57 12/30/202284,900 shares $303,942.00 +57.2%N/A0.6 $3.58 12/15/202254,000 shares $215,460.00 +50.0%N/A0.4 $3.99 11/30/202236,000 shares $148,320.00 -0.6%N/A0.4 $4.12 11/15/202236,200 shares $142,266.00 -67.5%N/A0.4 $3.93 10/31/2022111,300 shares $538,692.00 -9.9%N/A1.7 $4.84 10/15/2022123,500 shares $659,490.00 -34.2%N/A2.2 $5.34 9/30/2022187,600 shares $943,628.00 +11.0%N/A4 $5.03 9/15/2022169,000 shares $870,350.00 -0.2%N/A4.3 $5.15Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide MOR Short Interest - Frequently Asked Questions What is MorphoSys' current short interest? Short interest is the volume of MorphoSys shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,250,000 shares of MOR short. Learn More on MorphoSys' current short interest. What is a good short interest ratio for MorphoSys? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOR shares currently have a short interest ratio of 1.0. Learn More on MorphoSys's short interest ratio. Is MorphoSys' short interest increasing or decreasing? MorphoSys saw a decrease in short interest in April. As of April 30th, there was short interest totaling 1,250,000 shares, a decrease of 18.3% from the previous total of 1,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does MorphoSys' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MorphoSys: Avidity Biosciences, Inc. (11.91%), TG Therapeutics, Inc. (27.08%), Amicus Therapeutics, Inc. (9.71%), Arrowhead Pharmaceuticals, Inc. (7.74%), Maravai LifeSciences Holdings, Inc. (6.66%), Corcept Therapeutics Incorporated (22.07%), Merus (5.76%), Bausch Health Companies Inc. (5.73%), MoonLake Immunotherapeutics (14.00%), Janux Therapeutics, Inc. (9.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short MorphoSys stock? Short selling MOR is an investing strategy that aims to generate trading profit from MorphoSys as its price is falling. MOR shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MorphoSys? A short squeeze for MorphoSys occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOR, which in turn drives the price of the stock up even further. How often is MorphoSys' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: RNA Short Interest TGTX Short Interest FOLD Short Interest ARWR Short Interest MRVI Short Interest CORT Short Interest MRUS Short Interest BHC Short Interest MLTX Short Interest JANX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits